Wang Fengmei: Clinical Trials

1 trial sponsored by Wang Fengmei, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Not yet recruiting 1

Follow Wang Fengmei: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Daridorexant for Sleep Disturbance in Adults With Liver Cirrhosis
Daridorexant, Placebo - Liver Cirrhosis, Sleep Disturbance
Phase 4Not yet recruitingWang Fengmei1802026-09-012026-10-16

Conditions studied

Hepatic Encephalopathy (1)  ·  Liver Cirrhosis (1)  ·  Parasomnias (1)

Interventions

daridorexant (1)

Countries

China (1)